UNC Lineberger News

Anders presents at 13th Annual Round Asia Oncology Forum

Anders presents at 13th Annual Round Asia Oncology Forum

Carey Anders, MD, UNC Lineberger member and associate professor, was a presenter and moderator at The 13th Annual Round Asia Oncology Forum (RAOF) in Hong Kong on August 29 - 30, 2014. The theme of this year’s forum was “Expanding our armory in personalized cancer treatment.”

Anders presents at 13th Annual Round Asia Oncology Forum - Read More…

Eshelman gives $3 million gift to Center for Integrative Chemical Biology and Drug Discovery

Eshelman gives $3 million gift to Center for Integrative Chemical Biology and Drug Discovery

The UNC Eshelman School of Pharmacy has received a $3 million gift from philanthropist and pharmaceutical-industry executive Fred Eshelman. Eshelman’s gift will support the work of the School’s Center for Integrative Chemical Biology and Drug Discovery, led by UNC Lineberger member Stephen Frye, PhD. The center is dedicated to evaluating and developing potential drug targets discovered by UNC faculty.

Eshelman gives $3 million gift to Center for Integrative Chemical Biology and Drug Discovery - Read More…

2014 University Cancer Research Fund Innovation Awards announced

Six researchers have been awarded 2014 University Cancer Research Fund (UCRF) Innovation Awards for promoting innovative and new ideas in cancer research at the University of North Carolina at Chapel Hill.

2014 University Cancer Research Fund Innovation Awards announced - Read More…

Field of Hope honors cancer survivors and raises money for Kay Yow Cancer Fund

Field of Hope honors cancer survivors and raises money for Kay Yow Cancer Fund

UNC Health Care and Rex Healthcare co-sponsored “Field of Hope” at the Durham Bulls game on Saturday, August 23 with a portion of special ticket sales going to the Kay Yow Cancer Fund.

Field of Hope honors cancer survivors and raises money for Kay Yow Cancer Fund - Read More…

Lung Cancer Initiative of NC Hosts 4th Lung Cancer Advocacy Summit

Lung Cancer Initiative of NC Hosts 4th Lung Cancer Advocacy Summit

The Lung Cancer Initiative of NC hosted a statewide Lung Cancer Summit on August 23 at the N.C. Cancer Hospital. Lung cancer advocates were bolstered with training, resources, knowledge and the courage to take action. UNC Lineberger Comprehensive Cancer Center was the Host Sponsor of the event.

Lung Cancer Initiative of NC Hosts 4th Lung Cancer Advocacy Summit - Read More…

The Ras Tracker

The Ras Tracker

For more than 20 years, Sharon Campbell, PhD, has been studying Ras, a protein implicated in 30 percent of all cancers. Now she’s on the hunt for alternative ways to shut the protein down.

The Ras Tracker - Read More…

UNC researchers trade lab coats for running shoes

UNC researchers trade lab coats for running shoes

Kirsten Bryant, PhD, was recently recognized by the Pancreatic Cancer Action Network for her dual role in the fight against pancreatic cancer.

UNC researchers trade lab coats for running shoes - Read More…

UNC Lineberger researchers develop new approach to identify “drivers” of cancer

UNC Lineberger Comprehensive Cancer Center researchers have developed a new integrated approach to pinpoint the genetic “drivers” of cancer, uncovering eight genes that could be viable for targeted breast cancer therapy. The study, published online August 24 in Nature Genetics, was authored by Michael Gatza, PhD, lead author and post-doctoral research associate; Grace Silva, graduate student; Joel Parker, PhD, director of bioinformatics, UNC Lineberger; Cheng Fan, research associate; and senior author Chuck Perou, PhD, professor of genetics and pathology.

UNC Lineberger researchers develop new approach to identify “drivers” of cancer - Read More…

UNC researchers lead project to sequence rare kidney cancer

UNC researchers lead project to sequence rare kidney cancer

An international scientific collaboration led by researchers at UNC has revealed new insights into the unique genetic alterations that contribute to a rare form of kidney cancer.

UNC researchers lead project to sequence rare kidney cancer - Read More…

Older Patients with Limited Life Expectancy Still Receive Cancer Screenings

Older Patients with Limited Life Expectancy Still Receive Cancer Screenings

A substantial number of older patients with limited life expectancy receive routine screenings for prostate, breast, cervical and colorectal cancer even though the procedures are unlikely to benefit them, according to research conducted at the University of North Carolina at Chapel Hill.

Older Patients with Limited Life Expectancy Still Receive Cancer Screenings - Read More…

UNC Lineberger announces Developmental Research Award winners

UNC Lineberger Comprehensive Cancer Center has awarded nine researchers with Developmental Research Awards to support their work in advancing the fields of clinical/translational and population science cancer research.

UNC Lineberger announces Developmental Research Award winners - Read More…

UNC Cancer Care’s statewide multidisciplinary approach highlighted in Health Leaders Media

UNC Cancer Care’s statewide multidisciplinary approach highlighted in Health Leaders Media

A recent article published in the July/August 2014 issue of Health Leaders magazine focuses on some of UNC Lineberger’s strengths that rank it among the nation’s leading cancer centers.

UNC Cancer Care’s statewide multidisciplinary approach highlighted in Health Leaders Media - Read More…

U.S. News article highlights nation’s top cancer centers, cites UNC Lineberger

A recent U.S. News & World Report article highlights the nation’s cancer centers, focusing especially on those that the National Cancer Institute has designated as comprehensive cancer centers, citing advantages of patients being seen at or referred to these sites, including advances in technology and collaboration.

U.S. News article highlights nation’s top cancer centers, cites UNC Lineberger - Read More…

Largest cancer genetic analysis reveals new way of classifying cancer

Largest cancer genetic analysis reveals new way of classifying cancer

Researchers with The Cancer Genome Atlas (TCGA) Research Network have completed the largest, most diverse tumor genetic analysis ever conducted, revealing a new approach to classifying cancers. The work, led by researchers at the UNC Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill and other TCGA sites, not only revamps traditional ideas of how cancers are diagnosed and treated, but could also have a profound impact on the future landscape of drug development.

Largest cancer genetic analysis reveals new way of classifying cancer - Read More…

Genetic mutations linked to salivary gland tumors may point to new therapies

Genetic mutations linked to salivary gland tumors may point to new therapies

Faculty members at the University of North Carolina School of Dentistry, The Scripps Research Institute (TSRI) and other institutions have discovered links between a set of genes known to promote tumor growth and mucoepidermoid carcinoma, an oral cancer that affects the salivary glands. The discovery could help physicians develop new treatments that target the cancer’s underlying genetic causes.

Genetic mutations linked to salivary gland tumors may point to new therapies - Read More…

Remembering Dr. Feng Liu

Remembering Dr. Feng Liu

Feng Liu, PhD, a research professor in the Division of Molecular Pharmaceutics and UNC Lineberger member, died tragically Thursday, July 24, after being assaulted and robbed while walking in a neighborhood near campus. Liu was a dedicated colleague, educator and researcher focused on gene and drug delivery.

Remembering Dr. Feng Liu - Read More…

UNC researchers discover how Hepatitis C virus persists for years

UNC researchers discover how Hepatitis C virus persists for years

Hepatitis C virus (HCV) lingers in the human body for years, slowly damaging the liver and leading to liver diseases such as hepatitis, cirrhosis and liver cancer, which is often fatal. Research conducted at the University of North Carolina at Chapel Hill has discovered a mechanism that facilitates the virus achieving this life-long persistence. Chronic HCV infection is the leading cause of liver cancer in the United States.

UNC researchers discover how Hepatitis C virus persists for years - Read More…

UNC jumps 5 slots in 2014–15 U.S. News & World Report cancer rankings

UNC jumps 5 slots in 2014–15 U.S. News & World Report cancer rankings

UNC Hospitals is nationally ranked in cancer, taking the number 38th spot in the country. The latest ranking is up from 43rd in 2013.

UNC jumps 5 slots in 2014–15 U.S. News & World Report cancer rankings - Read More…

Amelio joins UNC School of Dentistry, UNC Lineberger

Amelio joins UNC School of Dentistry, UNC Lineberger

Dr. Antonio (Tony) Amelio recently began his joint appointment as assistant professor in the Department of Dental Ecology at the UNC School of Dentistry and as associate member at UNC Lineberger.

Amelio joins UNC School of Dentistry, UNC Lineberger - Read More…

Campbell awarded 2014 Battle Cancer Research Award

Campbell awarded 2014 Battle Cancer Research Award

Sharon Campbell, professor of biochemistry and biophysics, has been awarded the 2014 Hyman L. Battle Distinguished Cancer Research Award by the UNC School of Medicine. The award recognizes sustained, exceptional cancer research over a career by School of Medicine faculty.

Campbell awarded 2014 Battle Cancer Research Award - Read More…

Kim receives 2014 Bladder Cancer Research Innovation Award

Kim receives 2014 Bladder Cancer Research Innovation Award

The Bladder Cancer Advocacy Network (BCAN) has awarded William Kim, MD, associate professor of medicine, urology, and genetics, University of North Carolina at Chapel Hill and UNC Lineberger Comprehensive Cancer Center, with the 2014 Bladder Cancer Research Innovation Award to support his project “Immune Characterization of High-Grade Bladder Cancer.”

Kim receives 2014 Bladder Cancer Research Innovation Award - Read More…

UNC Lineberger researchers recognized by Thomson-Reuters as highly influential

UNC Lineberger researchers recognized by Thomson-Reuters as highly influential

Six UNC Lineberger members are among the most often-cited scientists in the world, according to the Thomson Reuters 2014 Highly Cited Researchers list.

UNC Lineberger researchers recognized by Thomson-Reuters as highly influential - Read More…

N.C. Medical Journal July/August issue highlights UNC Lineberger cancer research

N.C. Medical Journal July/August issue highlights UNC Lineberger cancer research

Cancer care in North Carolina is the focus of the July/August issue of the North Carolina Medical Journal (NCMJ). The issue, co-guest-edited by UNC Lineberger Comprehensive Cancer Center members Ethan Basch, MD, and Stephanie Wheeler, PhD, MPH, features articles on a wide variety of issues that determine how the state’s residents receive treatment for cancer.

N.C. Medical Journal July/August issue highlights UNC Lineberger cancer research - Read More…

Study in mice finds weight loss reduces progression of basal-like breast cancer

Obesity, epidemic in the U.S. and worldwide, is one of the important modifiable risk factors for breast cancer, especially a particularly aggressive subtype called basal-like breast cancer (BBC). Population studies have suggested that lifestyle interventions, including weight loss, could prevent a large proportion of this type of cancer; however, data on the effect of weight loss on BBC risk are limited and the mechanisms involved uncertain.

Study in mice finds weight loss reduces progression of basal-like breast cancer - Read More…

Doctors not adequately informing patients of cancer screening pros and cons, study finds

Though cancer screening has come a long way, physicians still do not thoroughly discuss with patients the advantages and disadvantages of these procedures before decisions are made to undergo the screenings, according to a new study co-authored by a physician from The University of North Carolina at Chapel Hill’s Gillings School of Global Public Health.

Doctors not adequately informing patients of cancer screening pros and cons, study finds - Read More…

UNC-developed tools improve accuracy of cancer DNA sequencing

The ability of researchers and physicians to use DNA sequencing to pinpoint the genetic mutations that cause cancer has led to greater understanding of the causes of the disease and development of drugs that treat tumors by targeting specific mutations. A pair of papers published by researchers at the UNC Lineberger Comprehensive Cancer Center reveal new tools that can improve the accuracy of tumor sequencing.

UNC-developed tools improve accuracy of cancer DNA sequencing - Read More…

Chen chosen for ASCO Leadership Development Program

The American Society of Clinical Oncology (ASCO) has chosen Ronald Chen, MD, MPH, assistant professor of radiation oncology and member of the UNC Lineberger Comprehensive Cancer Center, as a member of the 2014-2015 ASCO Leadership Development Program.

Chen chosen for ASCO Leadership Development Program - Read More…

WRAL story highlights bladder cancer vaccine study at UNC

A story that ran on Raleigh-based CBS affiliate WRAL focuses on a new bladder cancer vaccine being studied at UNC, called Impact Therapy. The vaccine works to target cancer cells with minimal side effects.

WRAL story highlights bladder cancer vaccine study at UNC - Read More…

Shared decision making still lacking for cancer screening

NEW YORK (Reuters Health) - When it comes to cancer screening, doctors often do not adequately discuss the balance of pros and cons with their patients, a new study suggests.

Shared decision making still lacking for cancer screening - Read More…

[1]